How do we implement the next generation of precision medicines and therapies to optimise patient experience? We sat down with senior representatives from Novartis, Merus, Labcorp, and Simcere Pharmaceuticals to discover the latest industry insights.
Breath testing offers a straightforward, noninvasive way to monitor our biology, providing a tool for applications including the early detection of diseases and optimisation of treatments through precision medicine.
Presented by Steven Anderson, Senior Vice President & Chief Scientific Officer, Labcorp Drug Development | Akanksha Gupta, Head of Immunology, Biomarker Solution Center, Labcorp Drug Development | Kelly Y Chun, Vice President, Research & Development, Labcorp Diagnostics
Dr. Bob Holt, Director of Biomarkers and Companion Diagnostics, BerGenBio ASA
21 February 2019
Genomic Markers & Precision Medicine
Search by Keyword
Filter by Subject Area
Filter by Content Type
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.